<code id='BEC15015E2'></code><style id='BEC15015E2'></style>
    • <acronym id='BEC15015E2'></acronym>
      <center id='BEC15015E2'><center id='BEC15015E2'><tfoot id='BEC15015E2'></tfoot></center><abbr id='BEC15015E2'><dir id='BEC15015E2'><tfoot id='BEC15015E2'></tfoot><noframes id='BEC15015E2'>

    • <optgroup id='BEC15015E2'><strike id='BEC15015E2'><sup id='BEC15015E2'></sup></strike><code id='BEC15015E2'></code></optgroup>
        1. <b id='BEC15015E2'><label id='BEC15015E2'><select id='BEC15015E2'><dt id='BEC15015E2'><span id='BEC15015E2'></span></dt></select></label></b><u id='BEC15015E2'></u>
          <i id='BEC15015E2'><strike id='BEC15015E2'><tt id='BEC15015E2'><pre id='BEC15015E2'></pre></tt></strike></i>

          Home / hotspot / leisure time

          leisure time


          leisure time

          author:fashion    Page View:6674
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In